Results 131 to 140 of about 9,814,118 (327)

Unequal Association of Mouse Allotypes with Antibodies of Different Specificities [PDF]

, 1968
Eberhardt Weiler, Ivan Jeanne Weiler
openalex   +1 more source

Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer

Molecular Oncology, EarlyView.
Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner, Markus Eckstein, Christoph Mark, Matthias W. Beckmann, Arndt Hartmann, Pamela L. Strissel, Reiner Strick   +6 more
wiley   +1 more source

Sensing antibody functions with a novel CCR8-responsive engineered cell

Acta Biochimica Polonica
Human chemokine receptor 8 (CCR8) is a promising drug target for immunotherapy of cancer and autoimmune diseases. Monoclonal antibody-based CCR8 targeted treatment shows significant inhibition in tumor growth.
Jianyu Hao, Yitong Lv, Xufeng Xiao, Lidan Li, Changyuan Yu   +4 more
doaj   +1 more source

Digoxin-specific antibodies. [PDF]

Proceedings of the National Academy of Sciences, 1967
James Chen, Vincent P. Butler
openaire   +3 more sources

EGFR‐STAT3 activation provides a therapeutic rationale for targeting aggressive ETV1‐positive prostate cancer

Molecular Oncology, EarlyView.
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva, Bernardo Orr, Ana Azeredo, Andreia Brandão, Manuel R. Teixeira, Paula Paulo   +5 more
wiley   +1 more source

VELOCITY OF COMBINATION OF ANTIBODY WITH SPECIFIC POLYSACCHARIDES OF PNEUMOCOCCUS

, 1942
Manfred M. Mayer, Michael Heidelberger
openalex   +1 more source

Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody. [PDF]

, 1966
WF Rosse, J. V. Dacie
openalex   +1 more source

Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

Arthritis & Rheumatology, 2018
A. Berti, R. Warner, Kent J. Johnson, D. Cornec, D. Schroeder, B. Kabat, C. Langford, G. Hoffman, F. Fervenza, C. Kallenberg, P. Seo, R. Spiera, E. S. St Clair, P. Brunetta, J. Stone, P. Merkel, U. Specks, P. Monach   +17 more
semanticscholar   +1 more source

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

Molecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon, Moa Stenudd, Margherita Zamboni, Kanar Alkass, Carl‐Johan Eriksson, Lars Pedersen, Alrik Schörling, Anna Thoss, Anders Bergh, Pernilla Wikström, Hans‐Olov Adami, Henrik Toft Sørensen, Henrik Druid, Jonas Frisén   +13 more
wiley   +1 more source

Differences in the Mechanism of In Vitro Immune Hemolysis Related to Antibody Specificity* [PDF]

, 1964
David Sears, Robert I. Weed, Scott N. Swisher   +2 more
openalex   +1 more source